AGIO
Agios Pharmaceuticals, Inc.
$31.67
Earnings Summary
Revenue | $7.1Mn |
Net Profits | $-95.94Mn |
Net Profit Margins | -1350.7% |
Highlights
Agios Pharmaceuticals, Inc.’s revenue jumped 64.8% since last year same period to $7.1Mn in the Q4 2023. On a quarterly growth basis, Agios Pharmaceuticals, Inc. has generated -4% fall in its revenue since last 3-months.
Agios Pharmaceuticals, Inc.’s net profit fell -155.71% since last year same period to $-95.94Mn in the Q4 2023. On a quarterly growth basis, Agios Pharmaceuticals, Inc. has generated -5.05% fall in its net profits since last 3-months.
Agios Pharmaceuticals, Inc.’s net profit margin fell -133.8% since last year same period to -1350.7% in the Q4 2023. On a quarterly growth basis, Agios Pharmaceuticals, Inc. has generated -9.43% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Agios Pharmaceuticals, Inc. post its latest quarter earnings
EPS Estimate Current Quarter | -1.65 |
EPS Estimate Current Year | -1.65 |
Highlights
Agios Pharmaceuticals, Inc.’s earning per share (EPS) estimates for the current quarter stand at -1.65 - a 0% jump from last quarter’s estimates.
Agios Pharmaceuticals, Inc.’s earning per share (EPS) estimates for the current year stand at -1.65.
Key Ratios
Key ratios of the Agios Pharmaceuticals, Inc. post its Q4 2023 earnings
Earning Per Share (EPS) | -1.72 |
Highlights
Agios Pharmaceuticals, Inc.’s earning per share (EPS) fell -356.72% since last year same period to -1.72 in the Q4 2023. This indicates that the Agios Pharmaceuticals, Inc. has generated -356.72% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-08-03 | -1.56 | -1.51 | 3.21% |
2023-05-04 | -1.7 | -1.47 | 13.53% |
2023-11-02 | -1.7 | -1.64 | 3.53% |
2024-02-15 | -1.65 | -1.72 | -4.24% |
₹0 US Stocks a/c Opening Fee